Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphomaRIZZIERI, David A; SAND, Gregory J; FOSTER, Tracy et al.Cancer. 2004, Vol 100, Num 11, pp 2408-2414, issn 0008-543X, 7 p.Article

Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular LymphomaSCHUSTER, Stephen J; NEELAPU, Sattva S; MCGAUGHEY, Dean S et al.Journal of clinical oncology. 2011, Vol 29, Num 20, pp 2787-2794, issn 0732-183X, 8 p.Article